✦ LIBER ✦

Baseline risk factors for relapse in HIV/HCV co-infected patients treated with PEG-IFN/RBV

✍ Scribed by A. Rivero-Juarez, J. A. Mira, A. Camacho, K. Neukam, I. Perez-Camacho…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Insulin resistance and HCV virologic res

✍ C. Donato; A. Cingolani; C. Pinnetti; A. De Luca 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Pharmacodynamics of PEG-IFN-α-2a in HIV/

✍ Harel Dahari; Evaldo S. Affonso de Araujo; Bart L. Haagmans; Thomas J. Layden; S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 614 KB

Predictive value of early virological re

✍ A.L. Ballesteros; S. Franco; D. Fuster; M.A. Martinez; L. Acosta; A. Salas; C. R 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 268 KB

547 Mitochondrial effects of a 24-week c

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Su1074 Meta-Analysis: Sustained Virologi

✍ Devaki, Pardha; Jencks, David S.; Nangia, Sharad; Marupakula, Vidyasagargoud; Ng 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 609 KB

652 Meta-Analysis: Sustained Virologic R

✍ Nguyen, Nghia; McCormack, Shelley A.; Yee, Brittany E.; Vutien, Philip; Nguyen, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 585 KB